Prelude Therapeutics Incorporated (PRLD) Earnings Call Analysis
NASDAQ · Unknown · Unknown
9/25
Growth 2
Margin 1
Expansion 3
Platform 1
Financial 2
latest quarter score
Earnings Reports
- 9